facebook twitter instagram linkedin google youtube vimeo tumblr yelp rss email podcast phone blog search brokercheck brokercheck Play Pause
Highlights From Vanguard's Market Outlook Thumbnail

Highlights From Vanguard's Market Outlook

We're pleased to share some highlights from Vanguard's May 2021 Market Perspectives, along with a link to the full article.

  • Vanguard is optimistic that growth will continue to pick up in the U.S. as the vaccine rollout continues, but the euro area will lag behind.
  • Core inflation will temporarily bump up above 2% in the second quarter, but long-term structural trends that have kept inflation low for more than a decade will continue to limit price increases.
  • Vanguard's long-term return projections show value stocks in the U.S. with higher expected returns than growth stocks, and international stocks having higher expected returns than U.S stocks.


Click below to see the full report:


Vanguard's Market Perspectives: May 2021


David Rappaport, CFP®

David is the Co-Founder and Chief Investment Officer of Rappaport Reiches Capital Management.  He acts as personal CFO to entrepreneurs and corporate executives, providing organization and clarity in their finances.  Please connect with David below.  He loves to talk about investing, financial planning, and Aspiritech, a non-profit hiring individuals on the autism spectrum.

The author does not intend to provide investment, legal or tax advice as these materials are for general educational purposes only.  Please consult your legal, tax or investment professional for advice on your particular situation. This material is derived from sources believed to be reliable, but its accuracy and the opinions based thereon are not guaranteed. It is not intended to be a solicitation, offer or recommendation to acquire or dispose of any investment or to engage in any other transaction. Investing involves risk including the possible loss of principal. Past performance does not guarantee future results. Please refer to RRCM’s Form ADV Part 2 for additional disclosures regarding RRCM and its practices.